Landscapes / Targets

EBV

11 drugs act on EBV, in 13 active trials · Any stage · updated 19 Nov 2026

FollowEvery change as it happens, and a Monday email

Drugs11

DrugHow it worksCompanyStageNext dateDetails
—
On the market 22 Aug 2028Phase 4 trial completes
Cell therapy
Pierre Fabre Medicament +1
Phase 3 Jun 2027Phase 2 trial completes
—
Moderna · Public MRNA
Phase 1/2 15 May 2027Phase 1 trial completes
—
Phase 1/2 4 Jun 2027Phase 1/2 trial completes
—
Phase 1/2 Sep 2027Phase 1/2 trial completes
Monoclonal antibody
Merck & Co. · Public MRK
Phase 1/2 31 Mar 2029Phase 1/2 trial completes
—
Phase 1/2 —
—
Phase 1 Nov 2027Phase 1 trial completes
—
Phase 1 31 Dec 2027Phase 1 trial completes
—
Eli Lilly · Public LLY
Phase 1 29 Feb 2028Phase 1 trial completes
—
Phase 1 Sep 2028Phase 1 trial completes

About this list

Included
Burkitt Lymphoma, Infectious Mononucleosis · Breakdown
Covers
11 of 28 active trials the registry tags as Epstein-Barr Virus Infections (39%)
Checked
11 of 11 drugs. How we check
Matches
The mechanism of checked drugs, and drug names, so a drug not checked yet may be missing.
Sources
ClinicalTrials.gov updated 19 Nov 2026 · openFDA updated 19 Nov 2026

Follow EBV

Following is part of Solo: you see every change to EBV the day it happens.

Solo

$49a month, excl. VAT

  • Follow up to 5 landscapes, companies or drugs
  • Every change, the day it happens
  • A Monday email with the week’s changes
Choose Solo

Free

$0no card

  • One landscape of your own, in full
  • The top 10 of everything else
Sign up free

Have an account? Sign in